BRKR
BRUKER CORPORATIONNasdaqResearch view
Healthcare · Laboratory Analytical Instruments · Mid-cap · SEC EDGAR FY 2025-12-31
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2025-12-31SectorHealthcare
Market Cap$9.3B
Enterprise Value$10.9B
Income$-8.3M
Sales$3.4B
Book/sh$16.30
Cash/sh$2.00
Dividend TTM$0.20
Payout-275%
Employees—
IPO—
Quick Ratio0.87
Current Ratio1.73
Debt/Eq0.76
EPS (ttm)$-0.15
EPS this Y-119.7%
EPS past 3/5Y—
Sales past 3/5Y10.7%
EPS Y/Y TTM-119.7%
Sales Y/Y TTM2.1%
Shs Outstand151.72M
ROA-0.1%
ROE-0.3%
ROIC-0.6%
Gross Margin45.9%
Oper. Margin2.0%
Profit Margin-0.2%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$2.4B
2021
$2.5B
2022
$3.0B
2023
$3.4B
2024
$3.4B
2025
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $2.4B | $2.5B | $3.0B | $3.4B | $3.4B |
| Gross Profit | $1.2B | $1.3B | $1.5B | $1.6B | $1.6B |
| Operating Income | $413.3M | $432.7M | $436.9M | $253.1M | $68.2M |
| Net Income | $280.6M | $298.5M | $428.5M | $113.8M | $-8.3M |
| Diluted EPS | $1.81 | $1.99 | $2.90 | $0.76 | $-0.15 |
| Operating Cash Flow | $282.4M | $274.4M | $350.1M | $251.3M | $134.1M |
| Free Cash Flow | $190.4M | $145.2M | $243.2M | $136.0M | $43.3M |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY25 cash-flow waterfall
Capital-light: capex is $90.8M against $134.1M operating cash
COMMUNITY · $BRKR0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Laboratory Analytical Instruments
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.